Chapter/Section Purchase

1 Study Coverage
1.1 Age Related Macular Degeneration Drug Product Introduction
1.2 Market by Type
1.2.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lucentis
1.2.3 Eylea
1.2.4 Avastin
1.2.5 Others
1.3 Market by Application
1.3.1 Global Age Related Macular Degeneration Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Age Related Macular Degeneration Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Age Related Macular Degeneration Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Age Related Macular Degeneration Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Age Related Macular Degeneration Drug Sales by Region
2.4.1 Global Age Related Macular Degeneration Drug Sales by Region (2017-2022)
2.4.2 Global Sales Age Related Macular Degeneration Drug by Region (2023-2028)
2.5 Global Age Related Macular Degeneration Drug Revenue by Region
2.5.1 Global Age Related Macular Degeneration Drug Revenue by Region (2017-2022)
2.5.2 Global Age Related Macular Degeneration Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Age Related Macular Degeneration Drug Sales by Manufacturers
3.1.1 Global Top Age Related Macular Degeneration Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Age Related Macular Degeneration Drug in 2021
3.2 Global Age Related Macular Degeneration Drug Revenue by Manufacturers
3.2.1 Global Age Related Macular Degeneration Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Age Related Macular Degeneration Drug Revenue in 2021
3.3 Global Age Related Macular Degeneration Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Age Related Macular Degeneration Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Age Related Macular Degeneration Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Age Related Macular Degeneration Drug Sales by Type
4.1.1 Global Age Related Macular Degeneration Drug Historical Sales by Type (2017-2022)
4.1.2 Global Age Related Macular Degeneration Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Age Related Macular Degeneration Drug Sales Market Share by Type (2017-2028)
4.2 Global Age Related Macular Degeneration Drug Revenue by Type
4.2.1 Global Age Related Macular Degeneration Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Age Related Macular Degeneration Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Age Related Macular Degeneration Drug Revenue Market Share by Type (2017-2028)
4.3 Global Age Related Macular Degeneration Drug Price by Type
4.3.1 Global Age Related Macular Degeneration Drug Price by Type (2017-2022)
4.3.2 Global Age Related Macular Degeneration Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Age Related Macular Degeneration Drug Sales by Application
5.1.1 Global Age Related Macular Degeneration Drug Historical Sales by Application (2017-2022)
5.1.2 Global Age Related Macular Degeneration Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Age Related Macular Degeneration Drug Sales Market Share by Application (2017-2028)
5.2 Global Age Related Macular Degeneration Drug Revenue by Application
5.2.1 Global Age Related Macular Degeneration Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Age Related Macular Degeneration Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Age Related Macular Degeneration Drug Revenue Market Share by Application (2017-2028)
5.3 Global Age Related Macular Degeneration Drug Price by Application
5.3.1 Global Age Related Macular Degeneration Drug Price by Application (2017-2022)
5.3.2 Global Age Related Macular Degeneration Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Age Related Macular Degeneration Drug Market Size by Type
6.1.1 North America Age Related Macular Degeneration Drug Sales by Type (2017-2028)
6.1.2 North America Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
6.2 North America Age Related Macular Degeneration Drug Market Size by Application
6.2.1 North America Age Related Macular Degeneration Drug Sales by Application (2017-2028)
6.2.2 North America Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
6.3 North America Age Related Macular Degeneration Drug Market Size by Country
6.3.1 North America Age Related Macular Degeneration Drug Sales by Country (2017-2028)
6.3.2 North America Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Age Related Macular Degeneration Drug Market Size by Type
7.1.1 Europe Age Related Macular Degeneration Drug Sales by Type (2017-2028)
7.1.2 Europe Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
7.2 Europe Age Related Macular Degeneration Drug Market Size by Application
7.2.1 Europe Age Related Macular Degeneration Drug Sales by Application (2017-2028)
7.2.2 Europe Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
7.3 Europe Age Related Macular Degeneration Drug Market Size by Country
7.3.1 Europe Age Related Macular Degeneration Drug Sales by Country (2017-2028)
7.3.2 Europe Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Age Related Macular Degeneration Drug Market Size by Type
8.1.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Age Related Macular Degeneration Drug Market Size by Application
8.2.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Age Related Macular Degeneration Drug Market Size by Region
8.3.1 Asia Pacific Age Related Macular Degeneration Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Age Related Macular Degeneration Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Age Related Macular Degeneration Drug Market Size by Type
9.1.1 Latin America Age Related Macular Degeneration Drug Sales by Type (2017-2028)
9.1.2 Latin America Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
9.2 Latin America Age Related Macular Degeneration Drug Market Size by Application
9.2.1 Latin America Age Related Macular Degeneration Drug Sales by Application (2017-2028)
9.2.2 Latin America Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
9.3 Latin America Age Related Macular Degeneration Drug Market Size by Country
9.3.1 Latin America Age Related Macular Degeneration Drug Sales by Country (2017-2028)
9.3.2 Latin America Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Type
10.1.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Application
10.2.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Age Related Macular Degeneration Drug Market Size by Country
10.3.1 Middle East and Africa Age Related Macular Degeneration Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Age Related Macular Degeneration Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Regeneron Pharmaceuticals
11.1.1 Regeneron Pharmaceuticals Corporation Information
11.1.2 Regeneron Pharmaceuticals Overview
11.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Regeneron Pharmaceuticals Recent Developments
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Corporation Information
11.2.2 Bayer HealthCare Overview
11.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer HealthCare Recent Developments
11.3 Novartis
11.3.1 Novartis Corporation Information
11.3.2 Novartis Overview
11.3.3 Novartis Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Novartis Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Novartis Recent Developments
11.4 Roche
11.4.1 Roche Corporation Information
11.4.2 Roche Overview
11.4.3 Roche Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Roche Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Recent Developments
11.5 Kanghong Pharma
11.5.1 Kanghong Pharma Corporation Information
11.5.2 Kanghong Pharma Overview
11.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Kanghong Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Age Related Macular Degeneration Drug Industry Chain Analysis
12.2 Age Related Macular Degeneration Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Age Related Macular Degeneration Drug Production Mode & Process
12.4 Age Related Macular Degeneration Drug Sales and Marketing
12.4.1 Age Related Macular Degeneration Drug Sales Channels
12.4.2 Age Related Macular Degeneration Drug Distributors
12.5 Age Related Macular Degeneration Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Age Related Macular Degeneration Drug Industry Trends
13.2 Age Related Macular Degeneration Drug Market Drivers
13.3 Age Related Macular Degeneration Drug Market Challenges
13.4 Age Related Macular Degeneration Drug Market Restraints
14 Key Findings in The Global Age Related Macular Degeneration Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer